13.05.2016 • News

Ajinomoto Sues Over Tryptophan Technology

Japanese food and chemical company Ajinomoto, together with its subsidiaries Ajinomoto Heartland and Ajinomoto Eurolysine in the US and France, respectively, has filed lawsuits against South Korea’s CJ CheilJedang Corp and three of its subsidiaries alleging infringement of its tryptophan production process.

The suits were filed on May 10 with the US International Trade Commission, the US District Court for the Southern District of New York and the District Court of Düsseldorf in Germany.

CJ CheilJedang makes tryptophan, an amino acid used in livestock feed, at its subsidiary in Indonesia, and Ajinomoto believes the manufacturing process employed infringes its patent rights. As a result, the three Ajinomoto companies have requested an injunction to stop the South Korean firm selling tryptophan and demanded compensation for damages.

Although it has not been disclosed how much compensation is being sought, it is estimated that it could include losses incurred from tryptophan sales for the past several years.

The Japanese producer said infringement of its intellectual property obstructs its R&D efforts and it will continue to pursue necessary measures to protect its legitimate rights.

CheilJedang is reported to be aware of the lawsuits but said it had not yet received any details.

 

 

The global market for tryptophan is reported to be worth an estimated $17.2 billion.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.